PlainRecalls
CPSC Moderate Active

GSK Consumer Health Recalls Five Excedrin Brands Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

Reported: December 23, 2020 Initiated: December 23, 2020 #21057

Product Description

This recall involves 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. The bottles are plastic with a child-resistant closure. For a full list of the recalled products, visit www.excedrin.com/products/discontinued.

Reason for Recall

Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).

Remedy

Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bottle, contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. Bottles without a hole can be retained and used as directed.

Frequently Asked Questions

What product was recalled?
This recall involves 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. The bottles are plastic with a child-resistant closure. For a full list of the recalled products, visit www.excedrin.com/products/discontinued.. Recalled by GSK Consumer Healthcare, of Warren, N.J.. Units affected: About 433,600.
Why was this product recalled?
Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).
What should consumers do?
Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bottle, contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. Bottles without a hole can be retained and used as directed.
Which agency issued this recall?
This recall was issued by the CPSC on December 23, 2020. Severity: Moderate. Recall number: 21057.